Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers R > Headlines for Repros Therapeutics Inc. > News item |
Repros Therapeutics files $100 million shelf for stock and preferreds
By Devika Patel
Knoxville, Tenn., Oct. 17 - Repros Therapeutics Inc. filed a $100 million shelf registration in an S-3 filing with the Securities and Exchange Commission. The shelf includes $74.26 million of previously registered but unsold securities.
The registration covers common stock, preferred stock, warrants, rights and units.
The securities may be structured as convertibles.
The Woodlands, Texas, biopharmaceutical company said proceeds will be used for general corporate purposes.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.